← all drugs

Ifosfamide Injection

in shortage · Oncology · Snapshot: 2026-10-09

Day 119

of this shortage, counting from the FDA's first posting on 06/12/2026

Manufacturers listed
Hikma Pharmaceuticals USA, Inc., Fresenius Kabi USA, LLC, Baxter Healthcare, SteriMax, Inc.
Reported reason(s)
Demand increase for the drug; Requirements related to complying with good manufacturing practices
Machine-readable
JSON for this drug

Presentations (8)

PresentationCompanyAvailabilityUpdated
Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9530-01)Hikma Pharmaceuticals USA, Inc. Unavailable 09/18/2026
Ifosfamide, Injection, 1 g/1 (NDC 63323-142-10)Fresenius Kabi USA, LLC Limited Availability 10/06/2026
IFEX, Injection, 3 g/60 mL (NDC 0338-3993-01)Baxter Healthcare Unavailable 10/02/2026
Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9531-01)Hikma Pharmaceuticals USA, Inc. Unavailable 09/18/2026
Ifosfamide, Injection, 1 g/20 mL (NDC 10019-925-01)Baxter Healthcare Available 10/02/2026
IFEX, Injection, 1 g/20 mL (NDC 0338-3991-01)Baxter Healthcare Available 10/02/2026
Ifosfamide, Injection, 1 g/1 (NDC 21586-211-02)SteriMax, Inc. Available 09/08/2026
Ifosfamide, Injection, 3 g/60 mL (NDC 10019-926-02)Baxter Healthcare Available 10/02/2026

History

Daily tracking of this drug began 2026-08-25 (the first day of the archive).

Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.

Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.